Related Experiment Video
Updated: Jan 16, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Tumor Microenvironment Metabolism-Modulating Nanomedicines for Enhancing Anti-Tumor Immunity
Jiajie Chen1,2,3, Simiao Fei1,4, Zhihao Cao1,4
1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, 650500, China.
Abstract:
Metabolic reprogramming within the tumor microenvironment (TME) sustains tumor cell survival, suppresses immune cell functionality, and drives immunosuppression, thereby impairing immunotherapeutic effectiveness and exacerbates clinical challenges. Encouragingly, advances in nanomedicine offer promising strategies to precisely and effectively remodel TME metabolism, including glycolysis, amino acid metabolism, lipid metabolism, etc., to potentiate anti-tumor immunity. This review delineates distinctive metabolic pathways in tumor cells, immune cells, and cancer stem cells (CSCs) within the immunosuppressive niches, detailing the rational design of nanomedicines with TME metabolism-modulating capabilities to enhance cancer immunotherapy while elucidating the concrete action mechanisms between nano-enabled metabolic modulation and immune response activation. Despite the promise, the pivotal challenges listed at the end demand resolution to advance TME metabolism-modulating nanotherapeutics for meeting personalized clinical anti-tumor demands.
More Related Videos
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...